Fitzpatrick Alexander A Insider Trades

Insider Trading History

Track insider trading activity for Fitzpatrick Alexander A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $958k 90,910 shares
Last Trade
Jun 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.6k 3,355 shares
$10.00
$10.54
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $2.53M 240,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 240,000 shares
$11.49
$10.54
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $945k 89,613 shares
Last Trade
May 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.45M 102,969 shares
$14.10
$10.54
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $2.11M 200,000 shares
Last Trade
May 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.43M 100,000 shares
$14.33
$10.54
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $2.03M 192,582 shares
Last Trade
May 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.43M 100,000 shares
$14.33
$10.54
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $1.61M 152,300 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 152,300 shares
$10.71
$10.54
Silverback Therapeutics
Silverback Therapeutics SBTX
Chief Legal Officer
Holding Value $1.76M 300,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67M 300,000 shares
$5.58
$5.87
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $3.16M 300,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67M 300,000 shares
$5.58
$10.54
Silverback Therapeutics
Silverback Therapeutics SBTX
Chief Legal Officer
Holding Value $524k 89,227 shares
Last Trade
Sep 29, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$272k 46,258 shares
$5.87
$5.87
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $940k 89,227 shares
Last Trade
Sep 29, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$175k 46,258 shares
$3.78
$10.54
Silverback Therapeutics
Silverback Therapeutics SBTX
Chief Legal Officer
Holding Value $252k 42,969 shares
Last Trade
Sep 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$235k 40,000 shares
$5.87
$5.87
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $453k 42,969 shares
Last Trade
Sep 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$145k 40,000 shares
$3.62
$10.54
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Legal Officer
Holding Value $7.38M 700,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.89M 700,000 shares
$8.42
$10.54
Silverback Therapeutics
Silverback Therapeutics SBTX
Chief Legal Officer
Holding Value $4.11M 700,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 700,000 shares
$5.87
$5.87
Evofem Biosciences
Evofem Biosciences EVFM
General Counsel And Secretary
Holding Value $4.39k 516,422 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.2M 300,000 shares
$7.34
$0.01
Evofem Biosciences
Evofem Biosciences EVFM
General Counsel And Secretary
Holding Value $1.84k 216,422 shares
Last Trade
Dec 31, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$676k 120,000 shares
$5.63
$0.01
Evofem Biosciences
Evofem Biosciences EVFM
General Counsel And Secretary
Holding Value $2.86k 336,422 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$139k 25,000 shares
$5.56
$0.01
Evofem Biosciences
Evofem Biosciences EVFM
General Counsel And Secretary
Holding Value $2.65k 311,422 shares
Last Trade
Jun 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$158k 10,000 shares
$15.75
$0.01
Evofem Biosciences
Evofem Biosciences EVFM
General Counsel And Secretary
Holding Value $2.56k 301,422 shares
Last Trade
May 20, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$541k 42,120 shares
$12.86
$0.01
Evofem Biosciences
Evofem Biosciences EVFM
General Counsel And Secretary
Holding Value $2.92k 343,542 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 350,000 shares
$48.75
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up